Project name: „Interprofessional co-operation in breast cancer therapeutic phase”
Project period: 09.01.2020-31.08.2023
Project code: 2020-1-EE01-KA203-077941
Coordinator: Tartu Healthcare College, Ms Siret Kivistik, firstname.lastname@example.org, temporary project manager from 04.01-23.05.2021 Mrs Tiina Kukkes email@example.com
Partners: Metropolia University of Applied Sciences, Oulu University of Applied Sciences, Western Norway University of Applied Sciences, Helse Bergen University Hospital, Tartu University Hospital
Associated Partner: University of Applied Sciences and Arts Western Switzerland, Haute Ecole de Sante Vaud
Objectives, outcomes and impacts
Objective 1. To review and create evidence based knowledge about interprofessional breast cancer care and treatments.
Objective 2. Improving the quality of breast cancer care and therapies and health care staff education related to it.
Objective 3. Testing and implementing the e-learning package at the European level.
The most important impact on the participating organizations as well as on other organizations that take the e-learning package in their educational use will be the harmonization of quality and contents of education in the field of interprofessional breast cancer treatment and its safety. The e-learning package linked also to EU EPALE dissemination platform gives open access resources for education also for such educational and health care institutions who otherwise could not afford or for some other reason are not able to have that kind of learning resources. At participant level this means equal possibility for health care professionals like radiation therapists, radiographers, biomedical laboratory scientists and nurses and their educators to acquire competences on e-learning in general, interprofessional breast cancer treatment and how to ensure its safety. In addition, studying from such e-learning materials increases health care staff and ordering clinical units’ understanding about different phases, procedures, actors and safety issues associated with breast cancer therapeutic phase
This project is supported by Erasmus+